Medications

Plain-language guides to the antipsychotic medications used to treat schizophrenia, sourced from FDA labeling.

Schizophrenia Overview Psychosis & Episodes Medications Side Effects Famous People with Schizophrenia Patient Experiences CBT for Psychosis Hospitalisation & Crisis Lifestyle & Wellbeing For Families & Caregivers Engineering Schizophrenia Research

Switching from oral antipsychotic to long-acting injectable

Switching from a daily oral antipsychotic to a long-acting injectable involves dose conversion, oral overlap, and timing. Here's a practical guide to what to expect.

Risperidone (Risperdal): how it works and what it treats

Risperidone is one of the workhorses of antipsychotic treatment — effective for schizophrenia, often well-tolerated at low to moderate doses, and available in long-acting injectable form.

Antipsychotics during fasting and Ramadan

Ramadan and other extended fasts intersect with antipsychotic dosing in ways that deserve a real conversation, not a flat 'do not fast.' Here is what tends to work.

Antipsychotics and St John's wort

St John's wort is sold as a 'natural' antidepressant supplement, but pharmacologically it is one of the most potent enzyme inducers people swallow — and it can lower antipsychotic levels meaningfully.

Mirtazapine augmentation in schizophrenia

Mirtazapine has a quietly growing evidence base as an add-on in schizophrenia — for negative symptoms, akathisia, sleep, and weight loss. The evidence is modest but real.

Brexpiprazole side effects: a milder partial-agonist profile

Brexpiprazole tends to produce less akathisia and insomnia than aripiprazole — but the trade-off includes a slightly higher tendency toward weight gain and sedation.

Lumateperone (Caplyta): the newest FDA-approved atypical

Lumateperone is one of the newest atypicals — distinctive mechanism, surprisingly mild side-effect profile, and a growing role in schizophrenia and bipolar depression.

Risperidone side effects: what's common, what's serious, what to do

Risperidone is generally well tolerated at low doses, but has a distinctive side effect profile — particularly hyperprolactinaemia and dose-dependent movement effects. Here's what to expect and how to handle them.

Lipid panel monitoring on antipsychotics

Antipsychotics can change cholesterol and triglyceride levels in just a few months. Lipid monitoring catches the shifts before they become heart disease.

Droperidol (Inapsine) in psychiatric emergencies

Droperidol is a fast-acting butyrophenone used in emergency rooms for severe agitation and as a powerful antiemetic. Its regulatory history is one of the most contentious in modern psychiatry.

Molindone: a less-prescribed first-generation antipsychotic

Molindone is a first-generation antipsychotic with one unusual property — it tends to cause weight loss rather than weight gain. It also faded from market availability for several years, then returned. Here is its story.

Opioids and antipsychotics: respiratory depression and constipation risk

Opioids and antipsychotics are increasingly co-prescribed. The combination is not categorically wrong but the additive risks — sedation, respiratory depression, constipation, QT — deserve real attention.

Abilify Maintena: the monthly aripiprazole injection

Abilify Maintena delivers a month of aripiprazole in one injection — an LAI option for patients who tolerate aripiprazole well and want monthly dosing for adherence support.

Managing antipsychotics when you're sick (flu, COVID, GI bug)

A stomach bug or a bad case of flu can interrupt a stable medication routine. Here is how to handle it without destabilizing weeks of psychiatric stability.

Antipsychotics and acetaminophen (Tylenol)

Acetaminophen — Tylenol or paracetamol — is one of the most common over-the-counter medications and is generally safe to combine with antipsychotics. The nuances mostly involve dose limits and liver health.

Mesoridazine (Serentil): a discontinued metabolite-derived antipsychotic

Mesoridazine, sold as Serentil, was an active metabolite of thioridazine marketed as an antipsychotic in its own right. It was discontinued in the US in 2004 because of QT prolongation concerns.

Xanomeline-trospium (Cobenfy / KarXT): the first non-D2 antipsychotic

After 70 years of dopamine-blocking antipsychotics, Cobenfy works differently — through muscarinic acetylcholine receptors. The trial results are real, but so are the side effects.

When to switch antipsychotics — and how to do it safely

Switching antipsychotics is common and sometimes essential — but it's also where most relapses happen. Here's how to recognise when it's worth doing and how a safe cross-taper works in practice.

Mesoridazine: another QT-related withdrawal

Mesoridazine, an active metabolite of thioridazine, followed its parent drug into the margins of practice for the same cardiac reason. Its short history is a useful case study.

Breastfeeding while taking antipsychotics

Most antipsychotics are compatible with breastfeeding to some degree. Here is what's known, what to watch for, and how the decision usually gets made.

Olanzapine/samidorphan (Lybalvi): blocking weight gain

Olanzapine works exceptionally well for many people but is one of the heaviest weight-gain antipsychotics. Lybalvi combines it with an opioid receptor blocker designed to soften that side effect.

Injection-site care and pain management for LAI antipsychotics

Injection-site soreness is the most common everyday side effect of long-acting injectable antipsychotics. Here's a practical guide to managing pain, what's normal, and what to flag.

Amantadine for antipsychotic-induced extrapyramidal symptoms

Amantadine sidesteps the cognitive and bowel costs of anticholinergics, making it a useful option for some patients with antipsychotic-induced parkinsonism — but it has its own set of trade-offs.

Risperdal Consta: the bi-weekly risperidone injection

Risperdal Consta was the first long-acting injectable atypical antipsychotic — given every two weeks. It still has a role, though newer LAIs have largely replaced it for new starts.

Glucose and A1c monitoring on antipsychotics

Several antipsychotics raise the risk of type 2 diabetes — sometimes within weeks. Routine glucose and A1c monitoring catches the changes early, while interventions still work well.

Fluphenazine (Prolixin): oral and decanoate use

Fluphenazine is one of the original high-potency phenothiazines and one of the first antipsychotics formulated as a long-acting depot injection. Both forms remain in use.

Cariprazine side effects: akathisia, insomnia, the long half-life

Cariprazine has the longest half-life of any oral antipsychotic, which shapes everything from akathisia onset to how dose changes feel. Here's the practical guide.

Cariprazine (Vraylar) for schizophrenia: what to expect

Cariprazine is a D3-preferring partial agonist with an unusually long half-life. The pharmacology shapes how it feels, how slowly it works, and how slowly it leaves the system.

Antipsychotics and surgery: what to tell your team

Surgery is stressful enough without losing track of psychiatric medication. Here is how patients and prescribers plan around the operating room.

Antipsychotics and cannabis: drug interactions

Cannabis interacts with antipsychotics in several layered ways — through liver enzyme induction, through additive sedation and cognitive effects, and through worsening of psychotic symptoms.